Stem cell infusion for kidney disease in type 2 diabetes
Part of Hormones & metabolism, Kidney & urinary clinical trials.
This trial tests whether infusing stem cells from umbilical cord blood can help slow kidney damage caused by type 2 diabetes. You would receive the stem cells through an IV, and researchers will monitor your kidney function over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You must have type 2 diabetes, confirmed by a blood test for C-peptide.
- You must have signs of kidney damage from diabetes, shown by specific lab values.
- You must have had a kidney biopsy that shows diabetic kidney damage.
- You must have been on a stable dose of your diabetes and blood pressure medicines for at least 3 months.
- You must not have any other serious health conditions like heart disease, active infections, or cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether stem cells from donated umbilical cords can safely help people with type 2 diabetes who also have kidney damage. It aims to see if this therapy can improve kidney function.
This trial focuses on improving how kidney damage is diagnosed and how treatment is planned for people with type 2 diabetes and kidney disease. It may help by using detailed medical history and (if done) kidney biopsy results to guide care more accurately.
This trial tests a new stem cell treatment for people with type 2 diabetes that is difficult to control with standard medications. The treatment uses a special kind of stem cell to try to improve blood sugar levels.
This trial tests if umbilical cord stem cells can improve the success of islet cell transplants for people with diabetes whose own pancreas no longer makes enough insulin. It aims to help patients achieve better blood sugar control and reduce dangerous low blood sugar episodes.
This trial tests whether injecting stem cells from donated umbilical cords can help people with kidney damage caused by type 2 diabetes. The goal is to see if this treatment can slow the decline in kidney function and safely improve their condition.
This trial tests whether a type of stem cell therapy can help people with chronic kidney disease caused by diabetes or high blood pressure. It may slow down kidney damage and improve kidney function.
Hear when a new Diabetic Nephropathy Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.